Australia
6clicks GRC Platform Adds Automated Cybersecurity Incident Tracking and Reporting to Meet New SEC Disclosure Requirements
Platform Now Helps Organizations Compile Details of Qualifying Events Centrally
for Tracking, Reporting, and Complete Auditability to Ensure Full Compliance
and Ease of Management
MELBOURNE, Australia, Nov. 13, 2023 /PRNewswire/ -- 6clicks
2023-11-14 06:29
1491
PYC'S FOURTH DRUG CANDIDATE HAS DISEASE-MODIFYING POTENTIAL IN POLYCYSTIC KIDNEY DISEASE
* PYC has developed a new drug candidate for the >5 million people worldwide [1] with Polycystic Kidney Disease (PKD) * This drug candidate has demonstrated efficacy in human models derived from the kidneys of patients with end-stage renal failure due to PKD[2] * PKD is a life-changing diseas...
2023-11-13 21:00
1509
Beyond2020 Improves Access to Clean Water for 10,000 Rural Malaysians
* Sustainable water fountains in 25 rural Malaysian communities provide clean, safe water, reducing waterborne illnesses ABU DHABI, UAE, Nov. 9, 2023 /PRNewswire/ -- Beyond2020, the UAE-driven humanitarian initiative, has installed water filters in 25 communities in theSabah and Sarawak regions...
2023-11-10 03:27
2485
Recruitment target achieved for Phase II SAR-Bombesin prostate cancer trial
SYDNEY, Nov. 7, 2023 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce that 50 patients have no...
2023-11-07 21:58
1432
David Beckham Signs Deal with TEMPUR to Promote The Benefits Of Sleep
LONDON, Nov. 6, 2023 /PRNewswire/ -- TEMPUR, a leading designer, manufacturer,
distributor, and retailer of premium bedding products worldwide, has today
announced the signing ofDavid Beckham as its newest brand ambassador.
2023-11-06 11:00
3764
PolyActiva reports promising clinical trial results for its 6-month sustained drug delivery, biodegradable ocular implant in glaucoma patients.
* Melbourne ophthalmology company PolyActiva is developing a unique biodegradable ocular implant that provides 6 months of sustained drug delivery for patients with glaucoma, the second most common cause of irreversible blindness. * The interim Phase 2a results demonstrate a sustained >20% re...
2023-11-03 05:15
615
CHIMERIC THERAPEUTICS ANNOUNCES FDA CLEARANCE OF IND APPLICATION FOR CHM 2101, A NOVEL CDH17 CAR T CELL THERAPY FOR ADVANCED GASTROINTESTINAL CANCERS
* FDA IND Clearance for CHM 2101, a novel 3rd generation CDH17 CAR T cell therapy * Anticipated to be the first CDH17 CAR T cell therapy to enter the clinic * Phase 1A clinical trial to initiate patient enrolment in 2024 * Phase 1A clinical trial will enroll patients with advanced Colorecta...
2023-10-31 19:00
1472
Clarity and PSI kick off SAR-bisPSMA Phase III
SYDNEY, Oct. 26, 2023 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, and PSI CRO AG ("PSI"), a global contract rese...
2023-10-26 21:00
1542
Enfinity Global to partner with Kyushu Electric Power in its operational portfolio in the United States
MIAMI, Oct. 26, 2023 /PRNewswire/ -- Enfinity Global Inc., a leader in renewable energy, today announced a definitive agreement for a minority sale in its 400 MW U.S. operating portfolio to the Japanese utility Kyushu Electric Power Co. Inc. (Kyushu Electric). Upon completion of the deal, Kyushu ...
2023-10-26 14:30
1740
Enfinity Global & ICG complete €400 million equity agreement
MIAMI, Oct. 25, 2023 /PRNewswire/ -- Enfinity Global, a leader in renewable energy, today announced the successful completion of €300 million equity funding from ICG, the global alternative asset manager. Another €100 million of equity funding is expected to close within a one-year period as part...
2023-10-25 21:32
2171
Xailient and Morse Micro Join Forces to Transform the Future of Smart Cameras
Wi-Fi HaLow™ Technology Enables Long-Range, Low-Power Connectivity for Smart Cameras SYDNEY and IRVINE, Calif., Oct. 25, 2023 /PRNewswire/ -- Xailient, the leader in edge artificial intelligence (AI) for computer vision, today announced a strategic partnership with Morse Micro, a fast-growing fa...
2023-10-25 21:05
1821
Certa Therapeutics' FT011 Granted US FDA Orphan Drug Designation for the Treatment of Systemic Sclerosis
MELBOURNE, Australia, Oct. 23, 2023 /PRNewswire/ -- Certa Therapeutics (Certa), a biotechnology company developing innovative precision therapies for patients with inflammatory and fibrotic diseases, today announces that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation ...
2023-10-23 21:30
1449
Actinogen to present progress on Phase 2 trials at the BIO Investor Forum, San Francisco and Clinical Trials on Alzheimer's Disease (CTAD) Conference, Boston
Xanamem® is an oral, brain-penetrant tissue cortisol synthesis inhibitor that has shown promising safety and clinical activity in three placebo-controlled trials and has the potential to treat a variety of neurodegenerative and neuropsychiatric diseases SYDNEY, Oct. 13, 2023 /PRNewswire/ -- Acti...
2023-10-13 20:00
2456
AACR OVARIAN CANCER CONFERENCE PRESENTATION
HIGHLIGHTS * Data from preclinical studies in ovarian cancer presented at premier international conference inBoston, USA. * Results indicate that Amplia's proprietary FAK inhibitor narmafotinib (AMP945) performs better than standard-of-care in models of chemotherapy-resistant high-grade ser...
2023-10-09 15:18
1411
First patient treated with Cu-67 SAR-Bombesin in theranostic prostate cancer trial
SYDNEY, Oct. 3, 2023 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce the dosing of the first ...
2023-10-03 20:58
2055
FlexRule's Decision-Centric Approach® methodology empowers organizations to make quality decisions, fast
MELBOURNE, Australia, Sept. 28, 2023 /PRNewswire/ -- FlexRule®, a leading Decision Management Suite, is proud to announce that its Decision-Centric Approach® has been officially trademarked. The Decision-Centric Approach® is a methodology that brings people, rules, data, and processes together...
2023-09-28 12:32
1576
Actinogen optimizes XanaMIA Phase 2b Alzheimer's disease trial design and provides general business update
Highlights Changes to the XanaMIA protocol reduce cost by AUD 30 million over the next two years and speed time to initial results while preserving the 36-week design and trial endpoints. UK sites added to the XanaCIDD trial of cognitive impairment associated with depression, due to report resu...
2023-09-26 20:51
1597
AVANCE CLINICAL APPOINTS US-BASED EXECUTIVES - SVP SCIENTIFIC AND REGULATORY AFFAIRS, AND DIRECTOR BUSINESS DEVELOPMENT
ADELAIDE, Australia and RALEIGH, N.C., Sept. 21, 2023 /PRNewswire/ -- Avance
Clinical, the award-winning Australian and North American market-leading CRO
for biotechs, announces two key appointments in the US to support its continued
global growth.
2023-09-21 19:30
1713
Körber celebrates partnership milestone with Geek+
HAMBURG, Germany, Sept. 20, 2023 /PRNewswire/ -- Global strategic partnership
empowers businesses to overcome efficiency, scalability and sustainability
challenges across supply chain
Körber
2023-09-20 18:34
1930
Norgine Strengthens Senior Leadership with the Appointment of Saulo Martiniano as Chief Operating Officer
AMSTERDAM, Sept. 11, 2023 /PRNewswire/ -- Norgine, a leading European specialist pharmaceutical company dedicated to improving the lives of patients, is pleased to announce the appointment ofSaulo Martiniano as its new Chief Operating Officer (COO). Saulo joins Norgine with a wealth of experience...
2023-09-11 15:00
1291
Week's Top Stories
Most Reposted
Supported by the Luxembourg Government, The Luxembourg House of Financial Technology (LHoFT) and the Asian Development Bank (ADB) Announce the 2nd Edition of Catapult | SE Asia 2025
[Picked up by 313 media titles]
2025-01-22 15:38
Blackpanda Recognized with Frost & Sullivan's Asia Pacific Company of the Year Award for Incident Response Excellence
[Picked up by 302 media titles]
2025-01-23 09:00
Agoda Expands Its Eco Deals Program Pledging Up to $1.5 Million to Fund Critical Conservation Projects Across 10 Asian Markets in Partnership with WWF
[Picked up by 292 media titles]
2025-01-23 09:00
Sephora Unveils Its First Film, "Beauty & Belonging" Celebrating Diversity and Authenticity
[Picked up by 288 media titles]
2025-01-24 08:00
Star-Studded Sponsor Line-up Takes Centre Court at the Singapore Tennis Open 2025
[Picked up by 287 media titles]
2025-01-28 10:49
Most Read
Supported by the Luxembourg Government, The Luxembourg House of Financial Technology (LHoFT) and the Asian Development Bank (ADB) Announce the 2nd Edition of Catapult | SE Asia 2025
2025-01-22 15:38
7163
BRI UMKM EXPO(RT) 2025 Returns: Showcasing Local Products to the World
2025-01-25 15:38
6367
U Power Announces Pricing of $5.0 Million Registered Direct Offering
2025-01-24 22:18
4975